Josep Tabernero, Director of the Vall d’Hebron Institute of Oncology (VHIO), presented data from the international phase III SUNLIGHT study during an Oral Abstract Session at this week’s American Society of Clinical Oncology’s (ASCO) 20th Annual Gastrointestinal Cancers Symposium, January 19-21, San Francisco, CA (U.S.).
SOURCE: Medical Research News – Health Research, Medicine Sciences Research, Health Sciences Research – Read entire story here.